Stay updated on Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial

Sign up to get notified when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now displays the completed dalfampridine trial record, including its study design, eligibility criteria, outcomes, locations, and record history, instead of an access-denied error.
    Difference
    48%
    Check dated 2026-11-08T04:54:02.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site's footer revision number changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T02:05:59.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T02:05:25.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:51:12.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:25:09.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error for the study record, with a simple 403 header and navigation replacing the previous content. Many study-related sections and terms were removed, resulting in an error-state page.
    Difference
    18%
    Check dated 2026-09-20T01:09:45.000Z thumbnail image

Stay in the know with updates to Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.